cp wire

CP Wire Articles


TP Therapeutics announced on 10/19/18 its completion of an $80 million round of mezzanine financing. Foresite Capital and venBio Partners led the investment syndicate, with participation from... read more

Fri, 10/19/18 - 09:29 am
admin

Vertex Pharmaceuticals (Europe) announced on 10/19/18 that the European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP) adopted a positive opinion for KALYDECO®(... read more

Fri, 10/19/18 - 09:13 am
admin

Takeda Pharmaceutical Company Limited (TSE: 4502) announced on 8/19/18 that intracranial efficacy data from the Phase 3 ALTA-1L (ALK in Lung Cancer Trial of BrigAtinib in 1st Line) trial showed... read more

Fri, 10/19/18 - 09:05 am
admin

Symberix announced on 10/18/18  has been awarded three Small Business Innovation Research (SBIR) grants from the National Institutes of Health (NIH), entered into a Research Collaboration... read more

Thu, 10/18/18 - 12:33 am
admin

LNC Therapeutics announced on 10/15/18 that it has signed an exclusive license agreement with Cornell University (Ithaca, NY, USA) for its Christensenella patent family.

Christensenella is... read more

Wed, 10/17/18 - 11:38 pm
admin


HealthCore, Inc., the outcomes research subsidiary of Anthem, Inc. (NYSE: ANTM) and Novo Nordisk Inc., which manufacturers the once weekly GLP-1 receptor agonist Ozempic (semaglutide), are... read more

Wed, 10/17/18 - 10:23 am
admin

Evotec AG (FSE: EVT) (XETRA: EVT) (OTC PINK: EVTCY) and Ferring Pharmaceuticals ("Ferring") today announced a strategic research alliance to discover and develop new small molecule therapies to... read more

Wed, 10/17/18 - 09:44 am
admin


New findings presented on 10/16/18 by CytoReason reveals possible new cellular players in the tumor microenvironment that could impact the treatment process for the most in-need patients –... read more

Tue, 10/16/18 - 09:38 am
admin
  • Non-Alcoholic Fatty Liver Diesease affects over 1 billion people globally
  • TAEUS provides information previously only available via CT and MRI cheaper and at the point of care
  • ... read more
Tue, 10/16/18 - 09:19 am
admin

AmpliPhi Biosciences Corporation (NYSE AMERICAN: APHB) announced on 10/12/18 the pricing of an underwritten public offering of 16,537,500 shares of its common stock (or pre-funded warrants to... read more

Fri, 10/12/18 - 09:36 am
admin

Bristol-Myers Squibb Company (NYSE:BMY) announced on 8/12/18 topline results from the Phase 3 CheckMate -331 study evaluating Opdivo (nivolumab) versus the current standard of care, topotecan or... read more

Fri, 10/12/18 - 09:23 am
admin

Apogenix, a biopharmaceutical company developing next generation immuno-oncology therapeutics, announced today that new data published in Journal of Immunotherapy[1]demonstrate the potent anti-... read more

Thu, 10/11/18 - 10:10 am
admin

Aytu BioScience, Inc. (NASDAQ: AYTU) announced on 10/11/18 the issuance of a U.S. patent covering the company's proprietary MiOXSYS® diagnostic platform for male infertility. This is the first... read more

Thu, 10/11/18 - 09:45 am
admin

Synspira, a privately held company developing a new class of inhaled glycopolymer-based therapeutics for the treatment of pulmonary disease, today announced that it has been granted Orphan... read more

Thu, 10/11/18 - 09:26 am
admin

Tetra Discovery Partners announced on 10/11/18 that the U.S. Patent and Trademark Office has issued a third patent covering the company’s selective phosphodiesterase-4D (PDE4D) inhibitor, BPN... read more

Thu, 10/11/18 - 09:16 am
admin
Data analytics startup Outlier, following its ... read more
Wed, 10/10/18 - 12:01 pm
admin
Delivers industry’s first cross-platform Root Cause Analysis feature and broadens integration support to include Amazon Redshift Spectrum, Apache Druid & Google Ads
... read more
Wed, 10/10/18 - 11:34 am
admin
  • Empagliflozin was estimated to extend life expectancy by 1 to 4.5 years on average
  • In Sept of 2018 it was announced that the class of drugs that includes empagliflozin was associated... read more
Wed, 10/10/18 - 10:08 am
admin
  • Ozanimod had a "beneficial effect" on cognitive processing speed
  • The drug also reduced relapse rates and MRI lesions compared to Avonex
  • Ozanimod is also in development for... read more
Wed, 10/10/18 - 09:50 am
admin

Pages

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.